{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T12:02:13Z","timestamp":1782475333003,"version":"3.54.5"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,3,15]],"date-time":"2016-03-15T00:00:00Z","timestamp":1458000000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s40261-016-0388-9","type":"journal-article","created":{"date-parts":[[2016,3,18]],"date-time":"2016-03-18T17:21:49Z","timestamp":1458321709000},"page":"453-462","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Health-Related Quality of Life During Routine Treatment with the SQ-Standardised Grass Allergy Immunotherapy Tablet: A Non-Interventional Observational Study"],"prefix":"10.1007","volume":"36","author":[{"name":"GRAZAX LQ-study group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Horn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert","family":"Zeuner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Schnitker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eike","family":"W\u00fcstenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,15]]},"reference":[{"issue":"Suppl 86","key":"388_CR1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1398-9995.2007.01620.x","volume":"63","author":"J Bousquet","year":"2008","unstructured":"Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 2008;63(Suppl 86):8\u2013160.","journal-title":"Allergy"},{"issue":"3","key":"388_CR2","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","volume":"34","author":"J Ware Jr","year":"1996","unstructured":"Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220\u201333.","journal-title":"Med Care"},{"issue":"1","key":"388_CR3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2222.1991.tb00807.x","volume":"21","author":"EF Juniper","year":"1991","unstructured":"Juniper EF, Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy. 1991;21(1):77\u201383.","journal-title":"Clin Exp Allergy"},{"key":"388_CR4","first-page":"162","volume":"16","author":"H-J Malling","year":"2006","unstructured":"Malling H-J, Lund L, Ipsen H, Poulsen LK. Safety and immunological changes during specific sublingual immunotherapy with SQ standardized grass allergen tablets. J Investig Allergol Clin Immunol. 2006;16:162\u20138.","journal-title":"J Investig Allergol Clin Immunol"},{"key":"388_CR5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1398-9995.2006.00959.x","volume":"61","author":"J Kleine-Tebbe","year":"2006","unstructured":"Kleine-Tebbe J, Ribel M, Herold DA. Safety of a SQ-standardised grass allergen tablet for sublingual immunotherapy: a randomized, placebo-controlled trial. Allergy. 2006;61:181\u20134.","journal-title":"Allergy"},{"key":"388_CR6","first-page":"338","volume":"16","author":"M Calderon","year":"2006","unstructured":"Calderon M, Essendrop M. Specific immunotherapy with high dose SQ standardised grass allergen tablets was safe and well tolerated. J Investig Allergol Clin Immunol. 2006;16:338\u201344.","journal-title":"J Investig Allergol Clin Immunol"},{"key":"388_CR7","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1399-3038.2007.00556.x","volume":"18","author":"MD Iba\u00f1ez","year":"2007","unstructured":"Iba\u00f1ez MD, Kaiser F, Knecht R, Armentia A, Sch\u00f6pfer H, Tholstrup B, Bufe A. Safety of specific sublingual immunotherapy with SQ standardized grass allergen tablets in children. Pediatr Allergy Immunol. 2007;18:516\u201322.","journal-title":"Pediatr Allergy Immunol"},{"key":"388_CR8","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jaci.2005.12.1358","volume":"117","author":"SR Durham","year":"2006","unstructured":"Durham SR, Yang WH, Pedersen MR, Johansen N, Rak S. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol. 2006;117:802\u20139.","journal-title":"J Allergy Clin Immunol"},{"key":"388_CR9","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jaci.2006.05.003","volume":"118","author":"R Dahl","year":"2006","unstructured":"Dahl R, Kapp A, Colombo G, de Monchy J, Rak S, Emminger W, Fern\u00e1ndez Rivas M, Ribel M, Durham SR. Efficacy and safety of sublingual immunotherapy with grass allergen tablet for seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol. 2006;118:434\u201340.","journal-title":"J Allergy Clin Immunol"},{"key":"388_CR10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1398-9995.2005.00949.x","volume":"61","author":"R Dahl","year":"2006","unstructured":"Dahl R, Stender A, Rak S. Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis. Allergy. 2006;61:185\u201390.","journal-title":"Allergy"},{"key":"388_CR11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jaci.2008.10.044","volume":"23","author":"A Bufe","year":"2009","unstructured":"Bufe A, Eberle P, Franke-Beckmann E, Funck J, Kimmig M, Klimek L, Knecht R, Stephan V, Tholstrup B, Wei\u03b2haar C, Kaiser F. Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy. J Allergy Clin Immunol. 2009;23:167\u201373.","journal-title":"J Allergy Clin Immunol"},{"key":"388_CR12","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jaci.2007.10.039","volume":"121","author":"R Dahl","year":"2008","unstructured":"Dahl R, Kapp A, Colombo G, De Monchy JG, Rak S, Emminger W, Riis B, Gr\u00f8nager PM, Durham SR. Sublingual grass allergen tablet immunotherapy provides sustained clinical benefit with progressive immunologic changes over 2 years. J Allergy Clin Immunol. 2008;121:512\u20138.","journal-title":"J Allergy Clin Immunol"},{"key":"388_CR13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jaci.2009.10.035","volume":"125","author":"SR Durham","year":"2010","unstructured":"Durham SR, Emminger W, Kapp A, Colombo G, de Monchy JGR, Rak S, Scadding GK, Andersen JS, Riis B, Dahl R. Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet. J Allergy Clin Immunol. 2010;125:131\u20138.","journal-title":"J Allergy Clin Immunol"},{"key":"388_CR14","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jaci.2011.12.973","volume":"129","author":"SR Durham","year":"2012","unstructured":"Durham SR, Emminger W, Kapp A, de Monchy JGR, Rak S, Scadding GK, Wurtzen PA, Andersen JS, Tholstrup B, Riis B, Dahl R. SQ-standardized sublingual grass immunotherapy: Confirmation of disease modification 2 years after 3 years of treatment in a randomized trial. J Allergy Clin Immunol. 2012;129:717\u201325.","journal-title":"J Allergy Clin Immunol"},{"key":"388_CR15","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jaci.2010.11.034","volume":"127","author":"M Blaiss","year":"2011","unstructured":"Blaiss M, Maloney J, Nolte H, Gawchik S, Yao R, Skoner DP. Safety of timothy grass allergy immunotherapy tablets in north American children and adolescents. J Allergy Clin Immunol. 2011;127:64\u20137.","journal-title":"J Allergy Clin Immunol"},{"key":"388_CR16","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jaci.2010.11.035","volume":"127","author":"HS Nelson","year":"2011","unstructured":"Nelson HS, Nolte H, Creticos P, Maloney J, Wu J, Bernstein DI. Efficacy and safety of timothy grass allergy immunotherapy tablet in north american adults. J Allergy Clin Immunol. 2011;127:72\u201380.","journal-title":"J Allergy Clin Immunol"},{"key":"388_CR17","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.anai.2013.11.018","volume":"112","author":"J Maloney","year":"2014","unstructured":"Maloney J, Bernstein DI, Nelson H, Creticos P, H\u00e9bert J, Noonan M, Skoner D, Zhou Y, Kaur A, Nolte H. Efficacy and safety of grass sublingual immunotherapy tablet, MK-7243: a large randomized controlled trial. Ann Allergy Asthma Immunol. 2014;112:146\u201353.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"388_CR18","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1398-9995.2009.02238.x","volume":"65","author":"L Fr\u00f8lund","year":"2010","unstructured":"Fr\u00f8lund L, Durham SR, Calderon M, Emminger W, Andersen JS, Rask P, Dahl R. Sustained effect of SQ-standardized grass allergy immunotherapy tablet on rhinoconjunctivitis quality of life. Allergy. 2010;65:753\u20137.","journal-title":"Allergy"},{"key":"388_CR19","unstructured":"GRAZAX\u00ae (75,000 SQ-T oral lyophilisate) [summary of product characteristics] (2006). Wedel, Germany: ALK; dated Oct 2006."},{"key":"388_CR20","volume-title":"ECDEU assessment manual for psychopharmacology, revised","author":"W Guy","year":"1976","unstructured":"Guy W. Clinical Global Impression. ECDEU assessment manual for psychopharmacology, revised. Rockville: National Institute of Mental Health; 1976."},{"issue":"1","key":"388_CR21","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0091-6749(98)70048-X","volume":"102","author":"EF Juniper","year":"1998","unstructured":"Juniper EF. Quality of life questionnaires: does statistically significant\u00a0=\u00a0clinically important? J Allergy Clin Immunol. 1998;102(1):16\u20137.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"388_CR22","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0091-6749(96)70135-5","volume":"98","author":"EF Juniper","year":"1996","unstructured":"Juniper EF, Guyatt GH, Griffith LE, Ferrie PJ. Interpretation of rhinoconjunctivitis quality of life questionnaire data. J Allergy Clin Immunol. 1996;98(4):843\u20135.","journal-title":"J Allergy Clin Immunol"},{"issue":"92","key":"388_CR23","first-page":"579","volume":"65","author":"A Horn","year":"2010","unstructured":"Horn A, Zeuner H, Wolf H, Schnitker J, W\u00fcstenberg E. Quality of life during routine treatment with the SQ-standardised grass allergy immunotherapy tablet. Allergy. 2010;65 (Suppl 92):579\u201380 (Poster presentation at the 29th EAACI-Congress, 05 to 09 June 2010, London, UK).","journal-title":"Allergy"},{"key":"388_CR24","first-page":"S49","volume":"19","author":"H Wolf","year":"2010","unstructured":"Wolf H, Horn A, Zeuner H, Schnitker J, W\u00fcstenberg E. Lebensqualit\u00e4t w\u00e4hrend der Routine-Behandlung mit der SQ-standardisierten Gr\u00e4ser-Allergie-Immuntherapietablette. Allergo J. 2010;19:S49 (Poster presentation at the 5th German Allergy Congress, 08 to 11 September 2010 Hannover, Germany).","journal-title":"Allergo J"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-016-0388-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40261-016-0388-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-016-0388-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T19:15:25Z","timestamp":1553627725000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40261-016-0388-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,15]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["388"],"URL":"https:\/\/doi.org\/10.1007\/s40261-016-0388-9","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,15]]}}}